Phase-I trial of combination chemotherapy and donor lymphocyte infusion for relapsed aggressive hematologic malignancies following allogeneic bone marrow transplantation.

被引：0
|
作者：
Mookerjee, B
Couzi, R
Seber, A
Miller, C
Noga, S
Douglas, T
Altomonte, V
Gore, S
Jones, R
Vogelsang, G
Fuchs, E
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
708
引用
收藏
页码：162A / 162A
页数：1
相关论文
共 50 条
  • [21] Donor leukocyte infusion (DLI) in relapsing hematologic malignancies after allogeneic bone marrow transplantation; The Princess Margaret Hospital experience.
    AlOmar, HM
    AlZahrani, H
    Lipton, J
    Meharchand, J
    Fyles, G
    Messner, H
    BLOOD, 1997, 90 (10) : 4445 - 4445
  • [22] Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells
    Mukaide, Hiromi
    Adachi, Yasushi
    Koike-Kiriyama, Naoko
    Suzuki, Yasuhiro
    Minamino, Keizo
    Iwasaki, Masayoshi
    Tsuda, Masanobu
    Nakano, Keiji
    Koike, Yasushi
    Shigematsu, Akio
    Kamiyama, Yasuo
    Ikehara, Susumu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (06) : 1309 - 1315
  • [23] Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial
    Odelia Amit
    Yael Bar On
    Galit Perez
    Liat Shargian-Alon
    Moshe Yeshurun
    Ron Ram
    Annals of Hematology, 2021, 100 : 817 - 824
  • [24] Overall survival after donor lymphocyte infusion for relapsed haematological malignancies after allogeneic haematopoietic cell transplantation
    Worel, N.
    Kalhs, P.
    Rabitsch, W.
    Mitterbauer, M.
    Woehrer, S.
    Kuzmina, Z.
    Leitner, G.
    Greinix, H. T.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S256 - S256
  • [25] Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial
    Amit, Odelia
    On, Yael Bar
    Perez, Galit
    Shargian-Alon, Liat
    Yeshurun, Moshe
    Ram, Ron
    ANNALS OF HEMATOLOGY, 2021, 100 (03) : 817 - 824
  • [26] Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    Depil, S
    Deconinck, E
    Milpied, N
    Sutton, L
    Witz, F
    Jouet, JP
    Damaj, G
    Yakoub-Agha, I
    BONE MARROW TRANSPLANTATION, 2004, 33 (05) : 531 - 534
  • [27] Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    S Depil
    E Deconinck
    N Milpied
    L Sutton
    F Witz
    J P Jouet
    G Damaj
    I Yakoub-Agha
    Bone Marrow Transplantation, 2004, 33 : 531 - 534
  • [28] Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation
    Bressoud, A
    Chapuis, B
    Roux, E
    Cabrol, C
    Jeannet, M
    Roosnek, E
    Helg, C
    BLOOD, 1996, 88 (05) : 1902 - 1903
  • [29] Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    Yakoub-Agha, I
    Depil, S
    Deconninck, E
    Milpied, N
    Sutton, L
    Witz, F
    Jouet, JP
    BONE MARROW TRANSPLANTATION, 2003, 31 : S182 - S182
  • [30] IMMUNOMODULATORY EFFECTS OF DONOR LYMPHOCYTE INFUSIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SOIFFER, RJ
    ALYEA, EP
    RITZ, J
    JOURNAL OF CLINICAL APHERESIS, 1995, 10 (03) : 139 - 143
12345